Budge James sold $4.9M of HNGE
Budge James (Chief Financial Officer) sold 47,720 shares of Hinge Health, Inc. (HNGE) at an average of $103.13 ($101.53–$104.34, $4.92M total) across 4 trades on 2026-10-12 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The transaction is material for Hinge Health and may influence short‑term sentiment, but the remaining insider ownership remains substantial.
Market read
First‑report insider sale of $4.9M by the CFO, likely to generate modest bearish pressure on HNGE.
What to watch
The CFO's remaining stake remains sizable; the sale may simply be portfolio rebalancing rather than a red flag.
Background
SEC Form 4 filings provide primary‑source disclosure of insider transactions. This filing reports a CFO's sale of nearly 48k shares at an average price of $103.13.
Ticker impact
CFO Budge James sold 47,720 shares for $4.9M via a 10b5-1 plan, reducing his stake to 296,728 shares.
likely pressure as the market prices in the CFO's sell-off
A $5M sale by the CFO is material for a mid‑cap health‑tech firm and is the first public disclosure of the transaction.
Market effects
Healthcare technology sector may see modest sell pressure as insiders reduce holdings.
US market participants may adjust exposure to HNGE in the near term.
Limited; impact confined to the company's stock and its immediate investors.
Counterpoint
The sale could be a routine 10b5-1 execution unrelated to fundamentals, offering a buying opportunity.
Key entities
- personBudge James
Chief Financial Officer of Hinge Health, Inc.
- companyHinge Health, Inc.
US‑listed digital health company (ticker HNGE).
